NCT05997433View on ClinicalTrials.gov

Efficacy of 7-day Versus 14-day Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori（SHARE2302)

NARecruitingINTERVENTIONAL
Enrollment

254

Participants

Timeline

Start Date

September 2, 2023

Primary Completion Date

August 30, 2024

Study Completion Date

August 30, 2024

Conditions
Helicobacter Pylori Infection
Interventions
PROCEDURE

7days bismuth quadruple

Amoxicillin 1000mg bid+ Tetracycline 500mg qid+ Bismuth + Tegoprazan 50mg bid\*7days

PROCEDURE

14 days bismuth quadruple

Amoxicillin 1000mg bid+ Tetracycline 500mg qid+ Bismuth + Tegoprazan 50mg bid\*14days

Trial Locations (1)

250012

RECRUITING

Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan

All Listed Sponsors
collaborator

Zibo Maternal and Child Health Hospital

UNKNOWN

collaborator

Zaozhuang Municipal Hospital

OTHER

collaborator

Binzhou Maternal and Child Health Hospital

UNKNOWN

collaborator

Jinxiang County People's Hospital

UNKNOWN

collaborator

Linyi Yizhou Hospital

UNKNOWN

collaborator

Yantai Penglai Traditional Chinese Medicine Hospital

UNKNOWN

collaborator

Shandong University of Traditional Chinese Medicine

OTHER

lead

Shandong University

OTHER